Summary
Tumour necrosis factor alpha (TNFα) and interleukin-2 (IL-2) are potential immunological mediators of pathogenetic changes in rheumatoid arthritis. We measured the concentrations of TNFα and IL-2 in plasma from 2 groups of patients suffering from rheumatoid arthritis (RA). One group had high and one had low disease activity. In addition, in connection with steroid treatment in the high disease activity group, TNFα was significantly increased in plasma from RA patients with high disease activity compared with those of low disease activity (p=0.0009). Furthermore, TNFα decreased significantly in relation to steroid medication, parallel to clinical improvement (p=0.016). All IL-2 concentration measurements were within the estimated normal range. The increased TNFα plasma levels in patients with rheumatoid arthritis with high disease activity, might result from activated white mononuclear cells in the inflamed joints. This might, in part, support the theory that TNFα is a possible mediator of pathogenetic changes known to occur in rheumatoid arthritis.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Bentsen, K. Review: Immune hormone (cytokines): Pathogenic role in autoimmune rheumatic and endocrine disease. Autoimmunity 1989, 2, 177–189.
Malkowsky, M., Sondell, P.M., Strober, W., Dalgleish, A.G. Review: The interleukins in a quiet disease. Clin Exp Immunol 1988, 74, 151–161.
Arend, W.P., Dayer, J.-M. Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis. Arthritis Rheum 1990, 33, 305–315.
Pettipher, E.R., Gerald, A.A., Henderson, B. Interleukin-1 induces leukocyte infiltration and cartilage proteoglycan degradation in the synovial joint. Proc Natl Acad Sci USA 1986, 83, 8749–8753.
Duff, G.W. Peptide regulatory factors in non-malignant disease. Lancet 1989, 24, 1 (8652), 1432–1435.
Dalton, B.J., Connor, J.R., Johnson, W.J. Interleukin-1 induces Interleukin-1 alpha and Interleukin-1 beta gene expression in synovial fibroblasts and peripheral blood monocytes. Arthritis Rheum 1989, 3, 279–287.
Bendtzen, K., Petersen, J., Halkjaer-Kristensen, J., Ingemann-Hansen, T. Interleukin-1-like activities in synovial fluids of patients with rheumatoid arthritis and traumatic synovitis. Rheumatol Int 1985, 5, 79–82.
Combe, B., Pope, R.M., Fischbach, M., Darnell, B., Baron & Talal, S. Interleukin-2 in rheumatoid arthritis: production of and response to interleukin-2 in rheumatoid synovial fluid, synovial tissue and peripheral blood. Clin Exp Immunol 1985, 59, 520–528.
Neale, M.L., Williams, B.D., Matthews, N. Tumor necrosis factor activity in joint fluids from rheumatoid arthritis patients. Br J Rheumatol 1989, 28, 104–108.
Hopkins, S.J., Meager, A. Cytokines in synovial fluids II. The presence of tumour necrosis factor and interferon. Clin Exp Immunol 1988, 73, 88–92.
Grau, G.E., Taylor, T.E., Molyneux, M.E. et al. Tumor necrosis factor and disease severity in children with falciparum malaria. N Engl J Med 1989, 320, 1586–1588.
Franchimont, P., Reuter, A., Vrindts-Gevaert, Y., Bastings, M., Malaise, M., Sondag, C., Frere, M.-C., Gysen, P. Production of tumor necrosis factor, interferon-gamma and interleukin-2 by peripheral blood mononuclear cells of subjects suffering from rheumatoid arthritis. Scand J Rheumatol 1988, 17, 203–212.
Kitas, G.D., Salmon, M., Allan, I.M., Bacon, P.A. The T-cell system in rheumatoid arthritis: Activated or defective. Scand J Rheumatol 1988, 76, 161–173.
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Espersen, G.T., Vestergaard, M., Ernst, E. et al. Tumour necrosis factor alpha and interleukin-2 in plasma from rheumatoid arthritis patients in relation to disease activity. Clin Rheumatol 10, 374–376 (1991). https://doi.org/10.1007/BF02206655
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1007/BF02206655